This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Jan Eric Jensen: Innovator in Recombinant Protein Production
Introduction
Jan Eric Jensen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. His innovative work has implications for various industries, including pharmaceuticals and research.
Latest Patents
Jan Eric Jensen holds a patent for a "Method for making recombinant proteins." This invention provides nucleic acid molecules and vector constructs that comprise scaffold/matrix attachment regions. It also outlines methods for using these regions in the industrial production of recombinant proteins and polypeptides. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Jensen is currently employed at Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to apply his innovative ideas in a practical setting, contributing to advancements in medical treatments and therapies.
Collaborations
Throughout his career, Jan Eric Jensen has collaborated with talented professionals, including Ruth Buemann Simesen and Anette Amstrup Pedersen. These collaborations have likely enriched his work and fostered a creative environment for innovation.
Conclusion
Jan Eric Jensen's contributions to the field of recombinant protein production highlight his role as an influential inventor. His work at Novo Nordisk A/S and his patented methods demonstrate his commitment to advancing biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile